Home » Topics » BioWorld Science

BioWorld Science
RSS

Amgen discovers new beta-secretase inhibitors

July 10, 2018

CPL-207-280CA demonstrates improved glycemic control and safety in vivo

July 10, 2018

Matinas collaborates with NINDS to develop HIV therapy based on LNC platform

July 10, 2018

Bellus Health initiates phase I study of BLU-5937 for the treatment of chronic cough

July 10, 2018

Catabasis announces plans for phase III trial of edasalonexent in DMD

July 10, 2018

MediciNova announces subgroup analyses from trial of MN-166 in ALS

July 10, 2018

Intrapulmonary penetration of ETX-2514SUL supports development for respiratory infections

July 10, 2018

Phase III trial of luspatercept in transfusion-dependent beta-thalassemia meets primary endpoint

July 10, 2018

Codexis begins dosing in first-in-human study of CDX-6114 for PKU

July 10, 2018

Assembly Biosciences initiates phase IIa studies of ABI-H0731 for HBV

July 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...